President Trump got 16 of America's largest pharmaceutical companies to the table. He applied real pressure, extracted public commitments on drug pricing that no previous administration had managed to get, and announced the deals from the White House. It should have been a historic win for American patients.

Then the SEC filings came out.

In Episode 6, Rob Burgess walks through what those 16 companies told their shareholders — in legally binding documents where they cannot misrepresent material fact — about what they actually agreed to. The gap between the public announcement and the private disclosure is what this episode is about.

In this episode:

• What the MFN deals actually required — and what companies committed to publicly vs. what they disclosed to investors
• Why Merck and Sanofi's SEC filings describe these as three-year deals — not the permanent reform the announcement suggested
• How the pricing provisions cover Medicaid only, leaving two thirds of Americans with private insurance untouched
• The Sanofi clause: a company that shook the president's hand then told shareholders it reserves the right to withhold drugs from American markets if pricing terms are "unacceptable"
• Why Eli Lilly and Pfizer's own filings acknowledge binding final agreements hadn't been signed when the deals were announced
• How pharma accepted three-year voluntary deals while their lawyers work to kill the longer mandatory Medicare programs in court
• Four specific things Congress and the administration should do right now — and why codification is the only thing Big Pharma is actually afraid of

The bottom line: This episode is not an argument against President Trump's drug pricing agenda. It's an argument for taking it further. The president started something real. The SEC filings show exactly how Big Pharma is planning to escape it. The answer is codification — permanent, enforceable, comprehensive law that doesn't expire in three years.

🔔 New episodes every week — subscribe so you don't miss one. 🌐 Get involved at BustBigPharma.com

#BustBigPharma #DrugPricing #MostFavoredNation #BigPharma #PharmaReform #MAHA #MakeAmericaHealthyAgain #Trump #DrugPriceReform #SECFilings #Codification #PrescriptionDrugPrices #AmericansForPharmaReform